Alnylam Pharmaceuticals
ALNY
#558
Rank
โ‚น4.087 T
Marketcap
โ‚น30,821
Share price
0.02%
Change (1 day)
41.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company